medizinische bildgebungsverfahren

Investigator-Initiated Trials (IITs) are pivotal in medical research, driven by independent investigators to explore new avenues and innovative medical approaches. These trials contribute significantly to advancing medical knowledge.

At mediri, we take pride in supporting researchers and clinicians in their IITs. With our expertise in imaging, we provide crucial assistance for these trials.
If you’re interested in learning more about our work or are involved in IITs, feel free to reach out to us.

We are extremely happy to have a third sponsor on board for our ASL Network Dinner 2024 in Singapore: Quantified Imaging.
A warm welcome to Professor Michael Chappell and Dr Tom Kirk who span out their company from the University of Nottingham in 2023.

To register for the event, please click here.

More info on the sponsors: mediri, Gold Standard Phantoms, Quantified Imaging

Did you know that Parkinson’s disease is the fastest-growing brain disease? At the same time, Parkinson’s disease is so variable, almost no 2 individuals’ symptoms and progression are the same. That is why at mediri, we are working every day to improve the diagnosis and therapy of Parkinson’s disease using advanced MR Imaging and Focused Ultrasound techniques.

For more details, you can have a look at this publication on automatic planning of MR-guided transcranial focused ultrasound treatment or this review article on blood-brain barrier dysfunction imaging.

We see a rapidly increasing need for medical imaging in clinical trials and in the development of standardized imaging biomarkers. In 2022, more than 1900 clinical trials were registered in Germany. In many of them, medical imaging is used in as a primary, quantitative and surrogate biomarker.

New AI developments across the healthcare industry, with radiology at the forefront, continue to increase the need for medical imaging core lab services.
As an Imaging CRO and Core Lab, we make your image-based clinical trials more efficient, faster and safer. This is especially important when it comes to multi-center studies that place high demands on comparability of image data.

Contact us to discuss our medical imaging solutions for reliable clinical trial results.

We cordially invite you to join the next ASL Network Dinner which will take place as usually in conjunction with ISMRM – this time in Singapore. mediri and Gold Standard Phantoms are looking forward to be your host on the evening of Sunday, May 5th in the Neon Pidgeon.

Meet leading experts as well as interested newbies in the research field of Arterial Spin Labelling and enjoy free drinks and food. See you there!
Don’t forget to register here.

Thank you for a great symposium in Frankfurt about clinical trial sample contracts 2.0 – Advancing implementation together. The symposium with 200 participants was jointly organized by (BVMA), Bundesverband der Pharmazeutischen Industrie, MFT Medizinischer Fakultätentag der Bundesrepublik Deutschland e.V., KKS-Netzwerk e. V. and the Verband Forschender Arzneimittelhersteller e.V. (VFA).

It was very enriching to receive new input and to have fruitful discussions. Perhaps just a small step, but an important one in making Germany more attractive as a place for clinical research.

We proudly announce that mediri has once again received the Digital Innovator 2024 award from CHIP in the category ”medical technology“.
In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one of the top recommended brands. See the full ranking here.

Many thanks to our partners from Universitätsklinik Bonn, INSIGHTEC, and Fraunhofer MEVIS for a great collaboration in the concluded project tcFUScontrol funded by ZIM. We aimed at developing an Advanced Therapy Control System for transcranial MR-guided Focused Ultrasound for Essential and Parkinson’s Tremor.

The consortium made progress in using Arterial Spin Labeling (ASL) MR images to measure the permeability of the blood brain barrier (BBB). Apart from that, a software tool for easier therapy planning computing the location of nerve fibre tracks in the brain based on Diffusion Tensor Imaging was developed.

The countdown is on: The final year of our DeepRAY project has begun. Together with our partners at Universitätsmedizin Mannheim we are working to integrate our WHITEBOX into the clinical workflow of routine abdominal CT scans. We will screen the patients for aortic aneurysms and dissections with AI-based algorithms (what else?).

The WHITEBOX enables easy and secure DICOM image transfer between the PACS and external server clusters for fast image analyses and notification of clinical staff.

First milestones are achieved: the WHITEBOX is a PACS node of the research PACS and retrospective data analysis can be performed easily. Now we are aiming to install our system in the clinic PACS for prospective evaluations.

The project DeepRAY is funded by the German Ministry of Education and Research.

Ein Arzt betreut einen Patienten am MRT Scanner

mediri wishes you merry christmas and a happy new year.